Treatment of acute coronary syndrome: part 2: ST-segment elevation myocardial infarction

Crit Care Med. 2012 Jun;40(6):1939-45. doi: 10.1097/CCM.0b013e31824e18c2.

Abstract

Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction.

Data sources: PubMed search and review of relevant medical literature.

Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed.

Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.

Publication types

  • Review

MeSH terms

  • Acute Coronary Syndrome / therapy*
  • Biomarkers
  • Critical Illness
  • Diagnosis, Differential
  • Electrocardiography
  • Humans
  • Medical History Taking
  • Myocardial Infarction* / complications
  • Myocardial Infarction* / diagnosis
  • Myocardial Infarction* / physiopathology
  • Myocardial Infarction* / therapy
  • Oxygen Consumption
  • Physical Examination
  • Reperfusion
  • Secondary Prevention
  • Thrombolytic Therapy
  • Thrombosis / prevention & control

Substances

  • Biomarkers